Abu Dhabi University (ADU) has partnered with FertiClinic Fertilization Group to establish the ‘FertiClinic Reproductive Research Lab’ at its Abu Dhabi campus, supporting the UAE’s national priorities under initiatives such as ‘We the UAE 2031’ and UAE Centennial 2071. The partnership aims to advance healthcare innovation, scientific research, and clinical innovation through a dedicated platform for reproductive medicine research and clinical collaboration.
Housed within ADU’s College of Health Sciences, the facility will include three specialized laboratories dedicated to in-vitro fertilization (IVF), andrology, and cryopreservation. Equipped with advanced technologies and specialized embryological infrastructure, the lab is designed to strengthen translational healthcare research and foster collaboration between university researchers and fertility specialists, contributing to advancements in reproductive medicine and fertility preservation.
Professor Ghassan Aouad, Chancellor of Abu Dhabi University, said: “Through this collaboration, Abu Dhabi University continues to strengthen its role in advancing impactful research, innovation, and industry collaboration in areas that directly contribute to healthcare advancement and societal wellbeing. The establishment of the FertiClinic Reproductive Research Lab reflects our commitment to providing students and researchers with access to advanced facilities and experiential learning opportunities that bridge academic knowledge with real-world healthcare applications. This commitment to research excellence is reflected in ADU’s worldwide recognition, including ranking 75th globally and second in the UAE for research quality in the Times Higher Education World University Rankings 2026, highlighting the strength of our academic and research ecosystem.”
Beyond supporting advanced scientific research, the partnership will provide students with practical learning opportunities through direct engagement with clinical experts and access to specialized laboratory environments. Faculty members and fertility specialists will also collaborate on scientific studies, medical publications, and educational initiatives. In addition, the facility will also host specialized workshops and regional conferences focused on reproductive health and fertility innovation.
Dr. Elsamawal El Hakim, CEO and Founder of FertiClinic Group, said: “Through this strategic partnership with Abu Dhabi University, we are proud to contribute to the advancement of reproductive medicine, scientific research, and fertility innovation in the UAE. The establishment of the FertiClinic Reproductive Research Lab represents an important step toward bridging clinical excellence with academic research, while creating new opportunities for knowledge exchange, advanced training, and patient-centered innovation. We believe this collaboration will support the future of fertility care and reinforce Abu Dhabi’s position as a regional leader in healthcare and medical research.”
This collaboration reflects a shared commitment to advancing specialized healthcare research and strengthening the connection between academia and clinical practice, in line with the United Nations (UN) Sustainable Development Goals (SDG) 3 (Good Health and Well-being), SDG 4 (Quality Education), and SDG 17 (Partnerships for the Goals). This initiative aims to support innovation in reproductive medicine, contribute to the UAE’s development of a research-driven healthcare ecosystem and enhance medical education and research in the region.
For more information about Abu Dhabi University, please visit www.adu.ac.ae
